ProPhase Labs, Inc. (PRPH)

Market Cap	1.00M
Revenue (ttm)	5.06M -80.6%
Net Income	-41.70M
EPS	-11.64
Shares Out	4.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	236,321
Average Volume	778,598
Open	0.2000
Previous Close	0.2080
Day's Range	0.1760 - 0.2175
52-Week Range	0.1320 - 7.8000
Beta	-0.54
RSI	27.77
Earnings Date	Mar 27, 2026

About ProPhase Labs

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, inc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 96
• Stock Exchange: OTCMKTS
• Ticker Symbol: PRPH

Financial Performance

In 2024, ProPhase Labs's revenue was $6.77 million, a decrease of -80.65% compared to the previous year's $34.98 million. Losses were -$53.36 million, 218.0% more than in 2023.